Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation.
Amo
Yasuyuki
Y
Masuzawa
Mikio
M
Hamada
Yuhko
Y
Katsuoka
Kensei
K
D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D016022:Case-Control Studies; D016228:Endothelial Growth Factors / Q000097:blood* / Q000378:metabolism; D005260:Female; D016158:Genes, p53 / Q000235:genetics*; D006394:Hemangiosarcoma / Q000097:blood / Q000235:genetics* / Q000503:physiopathology*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood* / Q000378:metabolism; D008222:Lymphokines / Q000097:blood* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009154:Mutation; D017354:Point Mutation; D011379:Prognosis; D011446:Prospective Studies; D012016:Reference Values; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000097:blood / Q000235:genetics* / Q000503:physiopathology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D014408:Biomarkers, Tumor; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors